Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2012-07-13 Director's Dealing
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
关于公司高级管理人员买入本公司股票的公告
Director's Dealing Classification · 100% confidence The document is a public announcement regarding a senior management personnel's purchase of the company's own shares. It includes details such as the name, position, purchase price, and number of shares bought by the executive. This fits the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives. The document is short and focused solely on insider share transactions, with no financial results or other report content. Therefore, the appropriate classification is DIRS (Director's Dealing).
2012-07-13 Chinese
关于公司董事买入本公司股票的公告
Director's Dealing Classification · 100% confidence The document is a public announcement regarding the purchase of company shares by two directors of the company. It details the names, positions, purchase prices, and quantities of shares bought by the directors. There is no financial report, earnings data, or management discussion. The content fits the definition of a Director's Dealing report, which reports personal share transactions by company directors and executives. The document is short and focused solely on insider share transactions, matching the DIRS category.
2012-07-12 Chinese
2012年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2012 second extraordinary shareholders meeting of the company. It includes voting results for multiple proposals, details on meeting attendance, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on shareholder voting outcomes and meeting decisions rather than financial results or management commentary. It is not a full annual or interim report, nor an earnings release or management discussion. It is not a proxy solicitation or a report publication announcement. The document fits the definition of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results from a shareholders meeting.
2012-07-10 Chinese
2012年第二次临时股东大会法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, and resolutions of a specific shareholders' meeting, namely the 2012 second extraordinary general meeting of the company. It details the legality and validity of the meeting's call, attendance, agenda, and voting results. It does not contain financial statements or financial performance data, nor is it a report or announcement of financial results. The document is focused on the legal aspects and validation of the shareholder meeting and its resolutions. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports on the official voting results and legality of the shareholder meeting resolutions.
2012-07-10 Chinese
关于召开2012年第二次临时股东大会的再次通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening a 2012 second extraordinary general meeting of shareholders, including meeting time, location, voting procedures (both onsite and online), agenda items for shareholder approval, and proxy voting instructions. It does not contain financial statements or results but is focused on informing shareholders about the meeting and how to participate and vote on specific corporate matters such as termination of a private placement plan, contract terminations, capital increase, loans, and amendments to the articles of association. The document is essentially a meeting notice and proxy solicitation material rather than a report or announcement of voting results. Therefore, it fits best under Proxy Solicitation & Information Statement (PSI). The document length is 4174 characters, which is consistent with a detailed meeting notice and proxy statement rather than a brief announcement or a full report.
2012-07-04 Chinese
有限售条件的流通股上市公告
Share Issue/Capital Change Classification · 95% confidence The document is a detailed announcement regarding the listing of restricted tradable shares (有限售条件的流通股上市公告) of the company 中源协和干细胞生物工程股份公司. It includes information about the shareholding changes, compliance with the equity reform plan, shareholder commitments, and the approval by the board and the sponsoring institution (东海证券有限责任公司). The document is not a financial report, earnings release, or management discussion but rather an official announcement about the listing of restricted shares becoming tradable. It contains detailed data about share quantities, shareholder changes, and regulatory compliance, which aligns with announcements related to share capital changes or share issue events. Therefore, the most appropriate classification is Share Issue/Capital Change (SHA). The document length (6807 characters) and content confirm it is a full announcement, not a brief notice or a report publication announcement.
2012-07-04 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.